ANVS
Annovis Bio Inc
1.20$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -35.6% | -26.8% | -11.2% | -53.5% | +85.9% | +0.3% | +3.0% | +21.9% | +39.1% | +190,968.1% | -28.2% | – | |
| – | +49.9% | -15.8% | +52.7% | -14.1% | +2.3% | -26.8% | -12.7% | +3.1% | -16.5% | +135,147.7% | +83.5% | – | |
| – | -29.7% | -25.2% | -0.6% | -43.5% | +53.5% | -6.7% | -0.2% | +18.6% | +30.5% | +85.6% | -20.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -61.1% | -96.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -107.9% | – | -33.3% | -631,917,850,100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.